GM16393
Fibroblast from Skin, Unspecified
Description:
GLUTARICACIDEMIA I
GLUTARYL-COA DEHYDROGENASE; GCDH
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases |
Class |
Disorders of Amino Acid Metabolism |
Biopsy Source
|
Unspecified
|
Cell Type
|
Fibroblast
|
Tissue Type
|
Skin
|
Transformant
|
Untransformed
|
Sample Source
|
Fibroblast from Skin, Unspecified
|
Relation to Proband
|
proband
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase,Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis |
|
Gene |
GCDH |
Chromosomal Location |
19p13.2 |
Allelic Variant 1 |
608801.0009; GLUTARICACIDEMIA I |
Identified Mutation |
ARG227PRO |
|
Gene |
GCDH |
Chromosomal Location |
19p13.2 |
Allelic Variant 2 |
608801.0008; GLUTARICACIDEMIA I |
Identified Mutation |
VAL400MET |
Remarks |
Clinically affected; the donor subject is a compound heterozygote; one allele carries a G-to-C transition (CGG>CCG) at nucleotide 716 (c.680) in exon 7 of the GCDH gene which results in a substitution of proline for arginine at codon 227 [ARG227PRO (R227P)]; the second allele carries a G-to-A transition (GTG>ATG) at nucleotide 1234 (c.1198) in exon 10 of the GCDH gene which results in a substitution of methionine for valine at codon 400 [VAL400MET (V400M)]. |
Split Ratio |
1:3 |
Temperature |
37 C |
Percent CO2 |
5% |
Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
Serum |
10% fetal bovine serum Not inactivated |
Substrate |
None specified |
Subcultivation Method |
trypsin-EDTA |
Supplement |
- |
|
|